ACWA Power Inks Deal to Construct Solar Plant in South Africa

ACWA Power signs a deal to invest in renewable energy projects in South Africa. (AFP)
ACWA Power signs a deal to invest in renewable energy projects in South Africa. (AFP)
TT

ACWA Power Inks Deal to Construct Solar Plant in South Africa

ACWA Power signs a deal to invest in renewable energy projects in South Africa. (AFP)
ACWA Power signs a deal to invest in renewable energy projects in South Africa. (AFP)

Saudi developer ACWA Power and the state-owned Central Energy Fund of South Africa are linking up to invest in renewable energy projects in the African country starting with the 100MW Redstone solar thermal power plant in the Northern Cape province.

South African President Cyril Ramaphosa announced the agreement during an official visit to Saudi Arabia.

Signed in Jeddah, the deal calls for the construction of the new solar plant in 2018.

The plant will include the latest solar energy storage techniques and boast a central salt receiver with 12 hours of thermal storage capacity.

ACWA Power chairman Mohammad Abunayyan said: “We are pleased to enter into this agreement, which further strengthens our efforts in supporting South Africa’s renewable energy program.”

“We are committed to providing the country with the most advanced and versatile solar technology solutions, which can efficiently and reliably produce clean energy for 24 hours if called upon to do so.”

“Our Redstone CSP plant will be able to deliver stable cost competitive electricity supply to more than 210,000 South African homes during peak demand periods, which are during the night,” said ACWA Power chief executive Paddy Padmanathan.

Padmanathan explained that the centered solar energy technique allows the generation of electricity even after sunset and without the need to use fuel.

He added that the new solar plant usage of the dry cooling technique to reduce dependency on water makes it the most attractive option among the available renewable energy sources in the world.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.